Blockade of EGFR improves responsiveness to PD-1 blockade in

Authors: Eri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, Sayoko Shinya, Yasuko Tada, Keisuke Kataoka, Kenta Tane, Eiichi Sato, Genichiro Ishii, Koichi Goto, Yasushi Shintani, Meinoshin Okumura, Masahiro Tsuboi, Hiroyoshi Nishikawa

Published: 2020-02-01

DOI: 10.1126/sciimmunol.aav3937

Source: Full article

---

Abstract

EGFR inhibitor erlotinib synergizes with anti–PD-1 in a mouse model of lung adenocarcinoma.